Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01505933 · ClinicalTrials.gov registry record · Phase 2
Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine
A Phase 2 study, sponsored by Milton S. Hershey Medical Center.
- Terminated
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT01505933 is a Phase 2 study that was terminated before completion, run by Milton S. Hershey Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT01505933, a Phase 2 study, was terminated before completion, sponsored by Milton S. Hershey Medical Center.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
Sedation is required in infants and children to successfully complete MRI while maintaining respiratory and hemodynamic stability. Limited access to the patient may pose a safety risk during MRI examination. Therefore, appropriate drugs need to be selected, administered, and titrated to achieve these objectives. Propofol is commonly used for sedation in children in the MRI setting because of its predictability, rapid onset, and offset of action. Dexmedetomidine has sedative and analgesic properties without affecting cardiovascular and respiratory stability. The rationale of this research is to assess the effect of these drugs on the upper airway and validate their use in children with upper airway disorders.
Interventions
- DRUG Dexmedetomidine
- DRUG propofol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2012-02 |
| Est. Completion | 2019-04-30 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01505933
The ClinicalTrials.gov registry entry for NCT01505933 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dexmedetomidine is the first listed.
NCT01505933 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01505933 about?
NCT01505933 is a clinical study titled "Airway Dimension Study in Children Undergoing MRI Sedated With Propofol and Dexmedetomidine". Sedation is required in infants and children to successfully complete MRI while maintaining respiratory and hemodynamic stability. Limited access to the patient may pose a safety risk during MRI examination. Therefore, appropriate drugs need to be selected, administered, and titrated to achieve thes...
What is the current status of trial NCT01505933?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2012-02. Estimated completion is 2019-04-30.
What interventions are being tested in trial NCT01505933?
The interventions under investigation include: Dexmedetomidine (DRUG), propofol (DRUG).
Who is sponsoring clinical trial NCT01505933?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.